Interleukin‐27 inhibits human osteoclastogenesis by abrogating RANKL‐mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Objective: Interleukin‐27 (IL‐27) has stimulatory and regulatory immune functions and is expressed in rheumatoid arthritis (RA) synovium. This study was undertaken to investigate the effects of IL‐27 on human osteoclastogenesis, to determine whether IL‐27 can stimulate or attenuate the osteoclast‐mediated bone resorption that is a hallmark of RA. Methods: Osteoclasts were generated from blood‐derived human CD14+ cells. The effects of IL‐27 on osteoclast formation were evaluated by counting the number of tartrate‐resistant acid phosphatase–positive multinucleated cells and measuring the expression of osteoclast‐related genes. The induction of nuclear factor of activated T cells c1 (NFATc1) and the activation of signaling pathways downstream of RANK were measured by immunoblotting. The expression of key molecules implicated in osteoclastogenesis (NFATc1, RANK, costimulatory receptors, and immunoreceptor tyrosine–based activation motif–harboring adaptor proteins) was measured by real‐time reverse transcription–polymerase chain reaction. Murine osteoclast precursors obtained from mouse bone marrow and synovial fluid macrophages derived from RA patients were also tested for their responsiveness to IL‐27. Results: IL‐27 inhibited human osteoclastogenesis, suppressed the induction of NFATc1, down‐regulated the expression of RANK and triggering receptor expressed on myeloid cells 2 (TREM‐2), and inhibited RANKL‐mediated activation of ERK, p38, and NF‐κB in osteoclast precursors. Synovial fluid macrophages from RA patients were refractory to the effects of IL‐27. In contrast to the findings in humans, IL‐27 only moderately suppressed murine osteoclastogenesis, and this was likely attributable to low expression of the IL‐27 receptor subunit WSX‐1 on murine osteoclast precursors. Conclusion: IL‐27 inhibits human osteoclastogenesis by a direct mechanism that suppresses the responses of osteoclast precursors to RANKL. These findings suggest that, in addition to its well‐known antiinflammatory effects, IL‐27 plays a homeostatic role in restraining bone erosion. This homeostatic function is compromised under conditions of chronic inflammation such as in RA synovitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · cited 1×
“In the microenvironment of the bone, myeloid-derived osteoclast precursors are exposed to stimuli that commit them to the osteoclast lineage (26).”
BackgroundOsteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878 · cited 3×
“The induction of NFATc1 expression by RANK is dependent on RANKL-induced activation of the MAPK and NF- B pathways (23,24), and we therefore investigated whether IL-27 inhibits RANK signaling.”
BackgroundSato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
T-Cell mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ.
Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., et al. (2000) · Nature · doi:10.1038/35046102 · Cited by 1,358
Stumhofer, J. S., Laurence, A., Wilson, E. H., Huang, E., Tato, C. M., Johnson, L. M., Villarino, A. V., Huang, Q., Yoshimura, A., Sehy, D., et al. (2006) · Nature Immunology · doi:10.1038/ni1376 · Cited by 955 · cited 1×
“suppresses the polarization of Th17 cells (12,13,51).”
Awasthi, A., Carrier, Y., Peron, J. P. S., Bettelli, E., Kamanaka, M., Flavell, R. A., Kuchroo, V. K., Oukka, M., & Weiner, H. L. (2007) · Nature Immunology · doi:10.1038/ni1541 · Cited by 804
Fos/AP‐1 proteins in bone and the immune system
Wagner, E. F., & Eferl, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00332.x · Cited by 537
Fitzgerald, D. C., Zhang, G.-X., El-Behi, M., Fonseca-Kelly, Z., Li, H., Yu, S., Saris, C. J. M., Gran, B., Ciric, B., & Rostami, A. (2007) · Nature Immunology · doi:10.1038/ni1540 · Cited by 529
The role of NFAT in osteoclast formation
TAKAYANAGI, H. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.071 · Cited by 442 · cited 2×
“tiation of precursor cells to osteoclasts (45,46).”
BackgroundMechanistic insight into osteoclast differentiation in osteoimmunology
Takayanagi, H. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0612-6 · Cited by 413 · cited 1×
“Recently, several differences in the regulation of osteoclastogenesis and bone remodeling between humans and mice have become apparent (48).”
BackgroundDAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features
Paloneva, J., Mandelin, J., Kiialainen, A., Böhling, T., Prudlo, J., Hakola, P., Haltia, M., Konttinen, Y. T., & Peltonen, L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030027 · Cited by 318 · cited 3×
“Since costimulatory signaling is important for NFATc1 expression, and TREM-2 plays a key role in costimulation of human osteoclastogenesis (33,34), these observations suggest down-regulation of TREM-2 as a mechanism by which IL-27 suppresses NFATc1 induction and inhibits human osteoclastogenesis.”
BackgroundCharacterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood
Sørensen, M. G., Henriksen, K., Schaller, S., Henriksen, D. B., Nielsen, F. C., Dziegiel, M. H., & Karsdal, M. A. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0725-9 · Cited by 143 · cited 1×
“As expected from previous observations (44), culture of human CD14 cells with M-CSF plus RANKL induced differentiation of large, multinucleated TRAP cells, which became readily apparent within 5 days after the addition of RANKL (Figures 1A and B).”
Result
Cited by
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Jones, S. A., & Jenkins, B. J. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0066-7 · Cited by 1,102
Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis
Chen, Z., Bozec, A., Ramming, A., & Schett, G. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0109-2 · Cited by 719
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683
Regulation of Osteoclast Differentiation by Cytokine Networks
Amarasekara, D. S., Yun, H., Kim, S., Lee, N., Kim, H., & Rho, J. (2018) · Immune Network · doi:10.4110/in.2018.18.e8 · Cited by 518
“It has been reported that IL-27 inhibits the expression of c-Fos and NFATc1 by blocking RANK-mediated ERK, p38, and NF-κB activation in OC precursors (119,120).”
Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis
Mateen, S., Zafar, A., Moin, S., Khan, A. Q., & Zubair, S. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.010 · Cited by 418
Metadata
- Authors
- Kalliolias, G. D., Zhao, B., Triantafyllopoulou, A., Park‐Min, K., & Ivashkiv, L. B.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2010-01-28
- Volume
- 62
- Issue
- 2
- Pages
- 402-413
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1837092909
- Cited by
- 87
- References
- 12
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.